Summary
Tolerance to the hemodynamic and antianginal effects of the organic nitrates develops rapidly during therapy. This has been documented with a variety of nitrate preparations and with different routes of administration. Dosing strategies designed to provide therapeutic plasma nitrate concentrations throughout the 24 hours of the day are regularly associated with the development of tolerance. Recent information indicates that dosing schedules providing a nitrate-free period will permit continued efficacy of the organic nitrates without tolerance development. This can be accomplished in serveral ways. With oral preparations of isosorbide dinitrate, medication can be given 3 times daily, omitting the evening dose. Buccal nitroglycerin is usually given 3 times daily after meals, and this has been shown not to be associated with tolerance. Likewise, preliminary studies suggest that removal of the nitroglycerin patches for a period of several hours each day will prevent the development of tolerance. Much needs to be learned about the nitrate-free period. With oral isosorbide dinitrate, it appears that 12 hours is required, but this could be substantially less with nitroglycerin preparations. It is also possible that several short periods with low nitrate levels each day would suffice. Thus, simply increasing the interval between dosing of oral preparations may provide an adequate, low, nitrate-free period.
Similar content being viewed by others
References
Johnson, EMJr, Harkey, AB, Blehm, DJ, et al. Clearance and metabolism of organic nitrates. J Pharmacol Exp Ther 1972;182:56–62.
Needleman, P, Lang, S, Johnson, EMJr. Organic nitrates: Relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther 1972;181:489–497.
Fung, H-L. Pharmacokinetics of nitroglycerin and long-acting nitrate esters. Am J Med 1983;72:suppl 6B:13–20.
Thadani, U, Fung, H-L, Darke, AC, et al. Oral isosorbide dinitrate in the treatment of angina pectoris: Dose-response relationship and duration of action during acute therapy. Circulation 1980;62:491–502.
Thadani, U, Fung, H-L, Darke, AC, et al. Oral isosorbide dinitrate in angina pectoris. Comparison of duration of action and dose response relation during acute and sustained therapy. Am J Cardiol 1982;49:411–419.
Dalal, JJ, Yao, L, Parker, JO. Nitrate tolerance: Influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin. J Am Coll Cardiol 1983;2:115–120.
Parker, JO, Fung, H-L, Ruggirello, D, et al. Tolerance to isosorbide dinitrate. Rate of development and reversal. Circulation 1983;68:1074–1080.
Parker, JO, VanKoughnett, KA, Fung, H-L. Transdermal isosorbide dinitrate in angina pectoris: Effect of acute and sustained therapy. Am J Cardiol 1984;54:8–13.
Parker, JO, Fung, H-L. Transdermal nitroglycerin in angina pectoris. Am J Cardiol 1984;54:471–476.
Reichek, N, Priest, C, Zimrin, D, et al. Antianginal effects of nitroglycerin patches. Am J Cardiol 1984;54:1–7.
Thadani, U, Hamilton, SF, Olson, E, et al. Transdermal nitroglycerin patches in angina pectoris: Dose titration, duration of effect, and rapid tolerance. Ann Int Med 1986;105: 485–492.
Elbright, GE. The effects of nitroglycerin on those engaged in its manufacture. JAMA 1914;62:201–202.
Lange, RL, Reid, MS, Tresch, DD, et al. Non-atheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation 1972;46:666–678.
Abrams, J. Nitrate tolerance and dependence. Am Heart J 1980;99:113–123.
Needleman, P, Johnson, EMJr. Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 1973;184:709–715.
Crandall, LA, Leake, CD, Loevenhart, AS, et al. Acquired tolerance to and cross tolerance between the nitrous and nitric acid esters and sodium nitrite in man. J Pharmacol Exp Ther 1931;41:103–119.
Thadani, U, Manyari, D, Parker, JO, et al. Tolerance to the circulatory effects of oral isosorbide dinitrate: Rate of development and cross-tolerance to glyceryl trinitrate. Circulation 1980;61:526–535.
Parker, JO, Fung, H-L, Riggirello, D, et al. Tolerance to isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin. J Am Coll Cardiol 1983;2:115–120.
Parker, JO, VanKoughnett, KA, Farrell, B. Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris. Am J Cardiol 1985;56: 724–728.
Parker, JO, Farrell, B, Lahey, KA, et al. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate. N Engl J Med 1987;316:1440–1444.
Rudolph, W, Blasini, R, Reiniger, G, et al. Tolerance development during isosorbide dinitrate treatment: Can it be circumvented? Z Kardiol 1983:suppl 3;72:195–198.
Zimrin, D, Reichek, N, Bogin, K, et al. Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation 1988;77: 1376–1384.
Kala, R, Hirvonen, P, Gordin, A, et al. Nitroglycerin ointment effective for seven hours in severe angina pectoris. Acta Med Scand 1983;213:165–170.
Reichek, N, Goldstein, RE, Redwood, DR, et al. Sustained effects of nitroglycerin ointment in patients with angina pectoris. Circulation 1974;50:348–352.
Danahy, DT, Aronow, WS. Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use. Circulation 1977;56:205–212.
Lee, G, Mason, DT, DeMaria, AN. Effects of long-term oral administration of isosorbide dinitrate on the antianginal response to nitroglycerin. Am J Cardiol 1978;41:82–87.
Thompson, RH. The clinical use of transdermal delivery devices with nitroglycerin. Angiology 1983;34:23–31.
Ignarro, LJ, Lippton, H, Edwards, JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside, and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:739–749.
Horowitz, JD, Antman, EM, Lorell, BH, et al. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation 1983;68:1247–1253.
Winniford, MD, Kennedy, PL, Wells, PJ, et al. Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine. Circulation 1986;73:138–142.
Parker, JO, Farrell, B, Rose, BF. Nitrate tolerance: The lack of effect of N-acetylcysteine. Circulation 1987;76:572–576.
Lis, Y, Bennett, D, Lambert, G, et al. A preliminary doubleblind study of intravenous nitroglycerin in acute myocardial infarction. Intensive Care Med 1984;10:179–184.
Fahmy, NR, Gavras, HR. Impact of captopril on hemodynamic and hormonal effects of nitroprusside. J Cardiovas Pharmacol 1985;7:869–874.
Cowan, JC, Bourke, J, Reid, DS, et al. Prevention of tolerance to nitroglycerin patches by overnight removal. Am J Cardiol 1987;271–275, 1987.
Dargie, H, Deanfield, J, Fox, K, et al. Nitrate tolerance avoided by use of a nitrate free interval (abstr). J Am Coll Cardiol 1988;11:43.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Parker, J.O. Nitrate tolerance in angina pectoris. Cardiovasc Drug Ther 2, 823–829 (1989). https://doi.org/10.1007/BF00133214
Issue Date:
DOI: https://doi.org/10.1007/BF00133214